SCOPE Recap: How AI Can Transform Patient Recruitment and Enrollment
Discover how Inato collaborates with sites and sponsors to reimagine patient identification and pre-screening with AI, enhance site-sponsor...
Discover how Inato collaborates with sites and sponsors to reimagine patient identification and pre-screening with AI, enhance site-sponsor...
Inato empowers site staff to make quick, informed decisions about patient eligibility
Early users reported time-savings of up to 90%, at a 95% accuracy rate.
Early users reported that Inato reduced their pre-screening times by more than 50%, and up to 90%
Discover how bridging trust gaps in clinical trials can drive faster, more inclusive research success—insights from Inato’s SCOPE Barcelona panel.
A bundle of oncology trials from AbbVie is coming to the Inato marketplace.
Joined by industry experts, Liz Beatty explored the implications of changing demographics on clinical trial design, participant recruitment, and...
Discover how Inato secured a spot in Fast Company's prestigious ranking of the most innovative companies in 2024.
Inato Co-Founder and Chief Strategy Officer, Liz Beatty, sat down with Dr. Daniel Fox and Monica Cuitiva from Save Our Sites to break down how Inato...
After moderating ACRP's webinar, Liz Beatty, shares how to turn the discussion into action with three key takeaways to guide the industry forward.